Eye Center, Linz-Ybbs, Austria.
J Cataract Refract Surg. 2010 Aug;36(8):1296-302. doi: 10.1016/j.jcrs.2010.03.039.
To evaluate intracorneal continuous ring (ICCR) implantation for the treatment of keratoconus.
Eye specialist centers, Europe and Middle East.
This study assessed the results of implantation of a MyoRing ICCR in 15 eyes with keratoconus. Outcome measures included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA) (spectacle correction), refraction, complications, and side effects. Postoperative follow-up was up to 1 year.
The study evaluated 15 eyes of 11 patients (8 men, 3 women) with a mean age of 35 years +/- 12 (SD) (range 22 to 60 years). Preoperatively, the mean central corneal thickness was 435 +/- 41 mum (range from 350 to 485 mum) and the mean keratometry (K) readings, 48.96 +/- 3.4 diopters (D) (range 43.75 to 56.62 D). Postoperatively, there was a statistically significant improvement in the UDVA, CDVA, K readings, manifest spherical and cylindrical refractive errors, and spherical equivalent (P<.05). The mean UDVA improved by almost 10 lines, from 0.07 (1.24 +/- 0.35 logMAR) to 0.56 (0.27 +/- 0.17 logMAR), and the mean CDVA improved by almost 3 lines, from 0.42 (0.40 +/- 0.17 logMAR) to 0.77 (0.12 +/- 0.10 logMAR). The mean K reading decreased by 5.76 D, from 48.96 D to 43.20 D. No serious intraoperative complications occurred. Side effects included glare and night-vision problems.
Treatment of keratoconus with ICCR implantation significantly improved visual function. The nomogram requires grading the disease using the K readings only. The UDVA and CDVA also improved during the first postoperative year.
Drs. Mahmoud and Venkateswaran have no financial or proprietary interest in any material or method mentioned. Additional disclosure is found in the footnotes.
评估角膜内连续环(ICCR)植入治疗圆锥角膜的效果。
欧洲和中东的眼科专家中心。
本研究评估了 15 例圆锥角膜患者植入 MyoRing ICCR 的结果。主要评估指标包括未矫正远视力(UDVA)、矫正远视力(CDVA)(眼镜矫正)、屈光度、并发症和副作用。术后随访时间最长为 1 年。
本研究评估了 11 名患者(8 名男性,3 名女性)的 15 只眼,平均年龄为 35 岁 +/- 12 岁(SD)(年龄范围为 22 至 60 岁)。术前,平均中央角膜厚度为 435 +/- 41 微米(范围为 350 至 485 微米),平均角膜曲率(K)读数为 48.96 +/- 3.4 屈光度(D)(范围为 43.75 至 56.62 D)。术后,UDVA、CDVA、K 读数、显性球镜和柱镜屈光误差以及等效球镜(P<.05)均有统计学显著改善。平均 UDVA 提高了近 10 行,从 0.07(1.24 +/- 0.35 logMAR)提高到 0.56(0.27 +/- 0.17 logMAR),平均 CDVA 提高了近 3 行,从 0.42(0.40 +/- 0.17 logMAR)提高到 0.77(0.12 +/- 0.10 logMAR)。平均 K 读数降低了 5.76 D,从 48.96 D 降低至 43.20 D。术中无严重并发症发生。副作用包括眩光和夜视问题。
ICCR 植入治疗圆锥角膜可显著改善视力功能。该图表仅使用 K 读数对疾病进行分级。术后第一年 UDVA 和 CDVA 也有所改善。
Mahmoud 博士和 Venkateswaran 博士没有任何材料或方法的财务或所有权利益。在脚注中发现了其他披露信息。